Facts

Value of the Biopharmaceutical Industry in Europe

The healthcare biotech sector is the driving force of major public health breakthroughs, providing benefits and novel solutions to patients.

DID YOU KNOW?

Social & economic impact

0%
Healthcare biotech companies in Europe of which 90% are private
0%
of healthcare biotech companies employ less than 50 persons
0
jobs in Europe
0
million patiens benefit from Biotech derived medicines worlwide

Driver of innovation in the life sciences industry

Biologicals represent:

0%
of revenues invested in Research and Development
0%
of medicines in the pharmaceutical pipeline
0%
of all marketed medicines come from biotech

Biopharmaceutical Development aiming for more targeted approaces to patients

Personalised medicine aims at improved prevention, diagnosis and treatment of diseases by using patients’ individual characteristics to identify the most appropriate care. It also delivers better patient outcomes by:

Ensuring better targeting of medicines

Improving response rates for medicines

Exposing fewer patients needlessly to the risk of side effects of medicine

Back to Overview